Anabella Villalobos's most recent trade in Coya Therapeutics Inc was a trade of 10,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coya Therapeutics Inc | Dr. Anabella Villalobos, PhD | Director | 02 Jan 2026 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Coya Therapeutics Inc | Dr. Anabella Villalobos, PhD | Director | 25 Feb 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | ||
| Coya Therapeutics Inc | Dr. Anabella Villalobos, PhD | Director | 01 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | ||
| Coya Therapeutics Inc | Dr. Anabella Villalobos, PhD | Director | 01 Jan 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | ||
| Coya Therapeutics Inc | Dr. Anabella Villalobos | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Common Stock, par value $0.0001 per share | |
| Coya Therapeutics Inc | Dr. Anabella Villalobos | Director | 03 Jan 2023 | 5,000 | 5,000 | - | - | Warrant to Purchase Common Stock |